Sarah Woody
Psychiatric/Mental Health · Claremore, OKNPI 1134984438
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 141 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 17 manufacturers, the largest accounting for just 13.1% — the pattern of someone who eats at a lot of different presentations.
Across 141 payments — averaging $35.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$661
- AbbVie$654
- Vanda Pharmaceuticals Inc.$537
- Corium, LLC$488
- Supernus Pharmaceuticals, Inc.$400
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$391
- plus $2K from 11 others
What the payments were for
- Food & beverage$5,050100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 6 | $661 |
| AbbVie | 20 | $654 |
| Vanda Pharmaceuticals Inc. | 9 | $537 |
| Corium, LLC | 21 | $488 |
| Supernus Pharmaceuticals, Inc. | 12 | $400 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 20 | $391 |
| Neurocrine Biosciences, Inc. | 6 | $325 |
| Axsome Therapeutics, Inc. | 7 | $314 |
| Alkermes, Inc. | 10 | $308 |
| Teva Pharmaceuticals USA, Inc. | 4 | $244 |
| Otsuka America Pharmaceutical, Inc. | 9 | $236 |
| E.r. Squibb & Sons, L.L.C. | 3 | $160 |
| Noven Pharmaceuticals, Inc. | 1 | $111 |
| Lundbeck LLC | 5 | $95 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $56 |
| Ironshore Pharmaceuticals Inc. | 3 | $54 |
| Sage Therapeutics, LLC | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,050 in reported general payments places this provider in the 85th percentile of 231 psychiatric/mental health providers in Oklahoma.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Venlafaxine Hcl ErVenlafaxine Hcl | 12 | $277 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Claremore
- Jonathan LurzClaremore$6K
- Rachael ToumaClaremore$5K
- Meryl AaronEdmond$23K
- Fernanda CooleyTulsa$16K
- Amy BoggsNorman$15K
- Amber BrownEdmond$15K
- Sylvie MawohOklahoma City$14K
- Nicole HolzerNorman$12K
- Pramila TraxlerTulsa$12K
- Sasha LounmalaMuskogee$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.